TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06036082

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy
Description: * Standing with feet together .~* Step standing .~* High step standing and trying to keep balanced.~* Single leg stance unilateral standing with assistance.~* Standing on a declined surface by using wedge.~* Standing with manual locking of the knees.~* Changing position.~* Gait training.~* Static and dynamic muscle contraction.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy
Description: * Standing with feet together .~* Step standing .~* High step standing and trying to keep balanced.~* Single leg stance unilateral standing with assistance.~* Standing on a declined surface by using wedge.~* Standing with manual locking of the knees.~* Changing position.~* Gait training.~* Static and dynamic muscle contraction.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy
Description: * Standing with feet together .~* Step standing .~* High step standing and trying to keep balanced.~* Single leg stance unilateral standing with assistance.~* Standing on a declined surface by using wedge.~* Standing with manual locking of the knees.~* Changing position.~* Gait training.~* Static and dynamic muscle contraction.
Study: NCT05165381

Intervention type: DEVICE
Intervention: Video PPG
Description: Contactless vital signs and stress measurement using video PPG technology. An iPad will be used to record a video of the participant's, which can then be converted to vital signs using a specialized algorithm.
Study: NCT02213406

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: yogurt
Description: Subjects will receive yogurt with varying fat concentrations
Study: NCT04991337

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Detraining group
Description: Detraining is defined as exercise corresponding to a heart rate ≤75% of maximum heart rate and ≤80% of the self-reported average weekly amount of exercise (hours/week) during the past six months, for a period of 16 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group
Description: At least three weekly sessions of high intensity exercise, corresponding to a heart rate ≥85% of maximum heart rate, and otherwise continue endurance exercise as usual.
Study: NCT05643079

Intervention type: PROCEDURE
Intervention: medializing calcaneal osteotomy and/or transfer of the flexor digitorum longus tendon (FDL) with metal/Bio-Tenodesis screws
Description: The calcaneus osteotomy is performed dorsal proximal to plantar distal with caution of the peroneal tendons and sural nerve. After mobilization the dorsal fragment is displaced medially by\~10mm. Thereafter, a guide wire is placed from plantar-lateral into the ventral portion of the calcaneus under fluoroscopic control. After stab incision and length measurement, the osteotomy is fixed with a Metal/Bio-Tenodesis screw(MBS). The lateral projection of the edge is straightened. Opening of the tendon sheath of the FDL muscle and dissection distally to Henry's node. Settling of the tendon and arming with a shuttle suture. Tendon diameter measurement. Place a guide wire at os naviculare directed from plantar to dorsal in 20°proximal guidance. Pull through the FDL tendon from plantar to dorsal and fixation with an MBS in 20°of pointed foot position and inversion with appropriate desired tension. The tendon is then sutured to the stump of the tibialis posterior tendon, retinaculum sutures.

Intervention type: PROCEDURE
Intervention: medializing calcaneal osteotomy and/or transfer of the flexor digitorum longus tendon (FDL) with Shark Screws®
Description: The calcaneus osteotomy is performed dorsal proximal to plantar distal with caution of the peroneal tendons and sural nerve. After mobilization the dorsal fragment is displaced medially by approx.10mm. Thereafter, a guide wire is placed from plantar-lateral into the ventral portion of the calcaneus under fluoroscopic control. After stab incision and length measurement, the osteotomy is fixed with a Shark Screw®. The lateral projection of the edge is straightened. Opening of the tendon sheath of the FDL muscle and dissection distally to Henry's node. Settling of the tendon and arming with a shuttle suture. Tendon diameter measurement. Place a guide wire at os naviculare directed from plantar to dorsal in 20°proximal guidance. Pull through the FDL tendon from plantar to dorsal and fixation with the Shark Screw® in 20°of pointed foot position and inversion with appropriate desired tension. The tendon is then sutured to the stump of the tibialis posterior tendon, retinaculum sutures.
Study: NCT05183919

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Treatment
Description: AKL-T01 multitasking digital treatment. AKL-T01 multitasking treatment employs perceptual discrimination attention/memory task as well as a continuous motor driving task.
Study: NCT06334406

Intervention type: OTHER
Intervention: Biological samples
Description: Blood samples will be collected at baseline, after the diagnostic TURBT, and D15 after the end of treatment in each cohort.~Tumor tissues will be collected at baseline for three patients.

Intervention type: OTHER
Intervention: Biological samples
Description: Blood samples will be collected at baseline, after the diagnostic TURBT, and D15 after the end of treatment in each cohort.~Tumor tissues will be collected at baseline for three patients.

Intervention type: OTHER
Intervention: Biological samples
Description: Blood samples will be collected at baseline, after the diagnostic TURBT, and D15 after the end of treatment in each cohort.~Tumor tissues will be collected at baseline for three patients.
Study: NCT04316910

Intervention type: DRUG
Intervention: General anesthetic
Description: General anesthesia was induced as follows: 0.3 mg kg-1 intravenous (IV) etomidate, 2 mg IV midazolam, 0.4 μg kg-1 IV sufentanil, and 0.2 mg kg-1 IV cisatracurium. Anesthesia was maintained with an end-tidal concentration of 2-3 vol% sevoflurane and 0.2-0.3 μg kg-1h-1 sufentanil to maintain the bispectral index between 40 and 60.

Intervention type: DRUG
Intervention: General anesthetic
Description: General anesthesia was induced as follows: 0.3 mg kg-1 intravenous (IV) etomidate, 2 mg IV midazolam, 0.4 μg kg-1 IV sufentanil, and 0.2 mg kg-1 IV cisatracurium. Anesthesia was maintained with an end-tidal concentration of 2-3 vol% sevoflurane and 0.2-0.3 μg kg-1h-1 sufentanil to maintain the bispectral index between 40 and 60.
Study: NCT05941481

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
Description: 1. Immunotherapy combined with chemotherapy (2 cycles): Intravenous tislelizumab (200mg, d1, q21d) in combination with XELOX regimen (capecitabine 1000 mg/m2 bid\*14d + oxaliplatin 130mg/m2, d1, q21d);~2. Concurrent radiotherapy: Within one week after the first initiation of chemo-immunotherapy, concurrent hypofractionated radiotherapy will be started: intensity modulated radiotherapy was given for tumors, total dose:30Gy/12f, 2.5Gy/f.
Study: NCT04712071

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: Patients with a diagnosis of Gulf War Illness using Kansas Criteria will be enrolled to receive a single 40 minute infusion of 0.5 mg/kg ketamine.
Study: NCT06011538

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: On-line, multi-media information on a specifically designed website for Same Day Discharge following Laparoscopic Hysterectomy
Description: A patient educational website that provides clear, easily accessible, patient friendly information explaining what SDD after laparoscopic hysterectomy is, why SDD may be beneficial and what to expect from decision for surgery, through to the admission to hospital and immediate, short and long term recovery.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: On-line, multi-media information on a specifically designed website for Same Day Discharge following Laparoscopic Hysterectomy
Description: A patient educational website that provides clear, easily accessible, patient friendly information explaining what SDD after laparoscopic hysterectomy is, why SDD may be beneficial and what to expect from decision for surgery, through to the admission to hospital and immediate, short and long term recovery.
Study: NCT05438173

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: EPA + DHA Ruby-O
Description: Subject will receive a single 1000 mg oral dose of EPA + DHA Ruby-O capsule

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: EPA + DHA Krill Oil
Description: Subject will receive a single 1000 mg oral dose of EPA + DHA krill oil capsule
Study: NCT04754789

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin
Description: preloading with high dose statins (atorvastatin 80mg) with loading dose of dual antiplatelet( asprine 300 mg and ticagrelor 180 mg) pre-primary PCI

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Aspirin
Description: Loading dose of dual antiplatelet (asprine 300 mg and ticagrelor 180 mg)
Study: NCT04702971

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flunarizine
Description: The flunarizine will be given per clinical routine
Study: NCT06190587

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Goji Berry
Description: As a functional food goji berry contains 19 amino acids, 21 minerals, a wide range of carotenoids (β-Carotene, Neoxanthin, Cryptoxanthin, Zeaxanthin), polysaccharides, flavonoids, phytosterols, vitamin A, C and E.
Study: NCT04702971

Intervention type: OTHER
Group type: OTHER
Intervention: healthy control
Description: no intervention for healthy control
Study: NCT05503290

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lullaby Project
Description: Our proposed intervention is the randomized participation of pregnant individuals with epilepsy in the Lullaby Project coordinated by a musical institution in Toronto. The Lullaby Project is an initiative first created by Carnegie Hall's Weill Music Institute. In this program, pregnant women and/or new mothers are paired with professional musicians to compose and write personal lullabies for their child(ren). Since its inception in 2011, the project has expanded globally and have helped numerous families write original lullabies for their newborns. The Lullaby intervention is unlike traditional music therapy as patients are actively participating in the creative song-writing process, not singularly in passive listening. Through sessions, participants will be given an opportunity to share experiences, experiment with musical arrangements, write lyrics, and receive positive feedback from the musician.
Study: NCT05266521

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: zLOCK Facet Stabilization System
Description: zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains
Study: NCT05724810

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active deep transcranial magnetic stimulation (dTMS)
Description: First, the investigators will find the position of the right abductor pollicis brevis (APB) motor cortex, finding the minimal motor threshold (MT) required for its activation, which determines the strength of the pulses. After determining the MT, dTMS stimulation is applied 6 cm anterior to the motor hot spot, at 120% of the MT. The target threshold is built toward gradually. During the first treatment, participants receive stimulation at 100% of the MT. During the second treatment, stimulation intensity increases to 110% of the MT. Beginning at the third treatment and continuing onward, participants receive treatment at 120% of the MT for the course of the treatment.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham dTMS
Description: Sham group will go through the same procedure. The only difference is that the sham card does not deliver stimulation.
Study: NCT04523727

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ferric citrate
Description: oral tablets
Study: NCT03899636

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Modified FOLFIRINOX Regimen
Description: Chemotherapy regimen of leucovorin, fluorouracil, irinotecan, and oxaliplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Modified FOLFIRINOX Regimen
Description: Chemotherapy regimen of leucovorin, fluorouracil, irinotecan, and oxaliplatin

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NanoKnife System
Description: IRE using NanoKnife System
Study: NCT05173207

Intervention type: DIAGNOSTIC_TEST
Intervention: Videofluoroscopic swallow exam with concurrent monitoring of respiratory-swallow coordination
Description: Participants will undergo simultaneous videofluoroscopy, nasal airflow and respiratory inductance plethysmography testing.
Study: NCT04874389

Intervention type: DIAGNOSTIC_TEST
Intervention: Multimodal Assessment
Description: Participants will complete BISQ/health questionnaire and proceed to each testing station with 15 minute rest breaks in between randomly ordered assigned stations.

Intervention type: DIAGNOSTIC_TEST
Intervention: Multimodal Assessment
Description: Participants will complete BISQ/health questionnaire and proceed to each testing station with 15 minute rest breaks in between randomly ordered assigned stations.
Study: NCT04715477

Intervention type: BEHAVIORAL
Intervention: Hospital Anxiety Depression Measure
Description: Hospital Anxiety Depression Measure
Study: NCT06146153

Intervention type: DIAGNOSTIC_TEST
Intervention: digital impression
Description: intra oral scanning
Study: NCT05661747

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vivos Grow/Vivos Way Device
Description: Children already using the device will be monitored to determined whether it improves symptoms of SDB
Study: NCT06146153

Intervention type: DIAGNOSTIC_TEST
Intervention: digital impression
Description: intra oral scanning

Intervention type: DIAGNOSTIC_TEST
Intervention: digital impression
Description: intra oral scanning
Study: NCT05242770

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Arm
Description: Participants randomized to this arm will only receive educational pamphlets with resources for sexual dysfunction and will not participate in physical therapy. Participants will be contacted at 3 months and 6 months to fill out two questionnaires about sexual function and quality of life. After 6months, if participants desire a referral to physical therapy, investigators will provide a referral.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Therapy Arm
Description: Participants will receive a referral to begin a pelvic physical therapy regimen. Participants will complete the sexual function and quality of life questionnaires after completion of the physical therapy regimen and again 3 months after. There will be a brief exit interview.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30)
Description: Questionnaire designed to measure cancer patients' physical, psychological and social functions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Female Sexual Function Index (FSFI)
Description: 19-item self-report inventory designed to assess female sexual function.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exit Interview
Description: 11-item questionnaire for participants to give feedback to investigators about teir experience with the intervention.
Study: NCT05533749

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GILL eHealth
Description: The aim of the successfully pilot-tested GILL eHealth intervention is to support mental health nurses and clinical nurse specialists in structured somatic screening and lifestyle promotion. The GILL eHealth intervention consists of two parts. Part one is OurGILL which focuses on systematic somatic screening and provides an overview of all somatic abnormalities. It promotes the prevention, early recognition and treatment of somatic problems. The second part is MyGILL. It provides the basis for drawing up a personalized lifestyle plan. The result of MyGILL is an overview of the performance of patients in different lifestyle areas. The eHealth intervention consists of an individual internet environment and is also supported by an app for mobile devices.
Study: NCT04350333

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT-I
Description: Strategies and techniques of Cognitive behavioral therapy for insomnia adapted for pregnant women: stimulus control; sleep hygiene; sleep restriction; cognitive control etc.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Assertive communication training
Description: Intervention based on improving assertive communication and regulating emotions.
Study: NCT05074030

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Personalized Normative Feedback
Description: Normative Feedback on drinking behaviors.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping-Motive Specific Personalized Feedback Intervention plus an Ecological Momentary Intervention (PFIcope+EMI)
Description: An EMA plus EMI intervention to decrease drinking to cope behaviors among emerging adults receiving psychiatric treatment.
Study: NCT06048146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental: FOLFOXIRI and Lateral lymph node dissection
Description: Irinotecan 150mg /m2, d1, oxaliplatin 85mg/m2, d1, 5-Fu, 2400mg/m2, pumped continuously for 46 hours and repeated for 14 days
Study: NCT06172985

Intervention type: OTHER
Intervention: No intervention
Description: Due to observational study
Study: NCT06048146

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Experimental: FOLFOXIRI and Lateral lymph node dissection
Description: Irinotecan 150mg /m2, d1, oxaliplatin 85mg/m2, d1, 5-Fu, 2400mg/m2, pumped continuously for 46 hours and repeated for 14 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
Description: Radiotherapy was administered five days a week (pelvic 2 Gy/ time, GT50 Gy) for five weeks with capecitabine (1650mg/m2/ day, orally divided into two doses). Intensity modulated radiotherapy (IMRT) was used

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
Description: Radiotherapy was administered five days a week (pelvic 2 Gy/ time, GT50 Gy) for five weeks with capecitabine (1650mg/m2/ day, orally divided into two doses). Intensity modulated radiotherapy (IMRT) was used
Study: NCT05165537

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIMM_MRS
Description: evaluation of new MRS methods
Study: NCT05424770

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education with crossword
Description: Afterwards, crossword activities prepared by the researcher will be implemented and students will be actively involved in the process. The researcher will also include a collaborative learning environment where students can exchange information with each other. After the completion of each puzzle, the researcher will make the necessary checks and corrections.
Study: NCT05668390

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: STALORAL® Birch 300 IR
Description: 2 treatment periods will consist of 2 steps: an escalation phase, where the treatment dose will gradually increase, followed by a maintenance phase.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STALORAL® Birch 300 IR
Description: 2 treatment periods will consist of 2 steps: an escalation phase, where the treatment dose will gradually increase, followed by a maintenance phase.
Study: NCT06148961

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: botox prior to modified lip repostioning
Description: botox injection prior to surgical intervention by 5 to 10 days A surgical marker was used to outline the boundaries of the surgical incision region.~the height of the superior incision was measured as 15 mm within the vestibule. Superior and inferior incisions were made with a scalpel blade number 15 and linked bilaterally by two vertical incisions.~A partial thickness dissection was used to remove the strip of the indicated mucosa, exposing the fascia of the connective tissue beneath. When necessary, all salivary glands and frenal attachments were removed. The surgical site was then properly closed using a periosteal simple interrupted suture was put in place prior to the continuous interlocking sutures. It was placed by commencing the needle 2 mm coronal to Per surgery site, 3 to 4 periosteal sutures were typically The new mucosal boundary to the gingiva was stabilized in its new place using this suture

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: botox prior to modified lip repostioning
Description: botox injection prior to surgical intervention by 5 to 10 days A surgical marker was used to outline the boundaries of the surgical incision region.~the height of the superior incision was measured as 15 mm within the vestibule. Superior and inferior incisions were made with a scalpel blade number 15 and linked bilaterally by two vertical incisions.~A partial thickness dissection was used to remove the strip of the indicated mucosa, exposing the fascia of the connective tissue beneath. When necessary, all salivary glands and frenal attachments were removed. The surgical site was then properly closed using a periosteal simple interrupted suture was put in place prior to the continuous interlocking sutures. It was placed by commencing the needle 2 mm coronal to Per surgery site, 3 to 4 periosteal sutures were typically The new mucosal boundary to the gingiva was stabilized in its new place using this suture
Study: NCT04480619

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ga-68-PEG-Αvβ3-IAC
Description: Clinical management and diagnosis of angiogenic Breast Cancer.
Study: NCT04323930

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eyeWatch
Description: The eyeWatch system will be implanted as per the manufacturer's instruction, and trabeculectomy will be performed using mitomycin C as per standard surgical protocols.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eyeWatch
Description: The eyeWatch system will be implanted as per the manufacturer's instruction, and trabeculectomy will be performed using mitomycin C as per standard surgical protocols.
Study: NCT05888974

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac ultrasonography
Description: During the inclusion visit, the patient will receive 3 cardiac ultrasonography. The first one will be performed at the time of the initiation of the 500mL vascular filling (T0), without delaying and the second one after the end of the filling (Tfin). These first two ultrasound are part of standard practice. A third will be performed 20 minutes after the end of the vascular filling (Tfin+20).
Study: NCT05596383

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D 5000 IU
Description: Intervention vitamin D 5000 IU per day, duration six months, dosage form chewable tablet

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo